Ruben Alfonso
Parotid gland cancer, a rare but significant malignancy, poses considerable challenges in diagnosis and treatment due to its heterogeneous nature. Recent advancements in molecular biology have unveiled critical insights into the molecular pathways driving parotid cancer. This review aims to elucidate the key molecular mechanisms involved in parotid cancer pathogenesis and highlight potential therapeutic targets that could pave the way for novel treatment strategies.
分享此文章